Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting.

Carolina VitaleAngelantonio Maglio Corrado PelaiaMaria D'AmatoLuigi CiampoGiulia PelaiaAntonio MolinoAlessandro Vatrella

Published in: Journal of clinical medicine (2023)

Our findings support the long-term effectiveness of benralizumab in severe OCS-dependent asthma in a real-life setting, suggesting potential reductive effects on costs and complications such as adverse pharmacological events.

Keyphrases

randomized controlled trial
systematic review
chronic obstructive pulmonary disease
lung function
risk factors
early onset
emergency department
human health
allergic rhinitis
risk assessment
cystic fibrosis
bone marrow
air pollution
climate change